Company Profile for Amneal Pharmaceuticals
Amneal Pharmaceuticals (NYSE: AMRX), based in Bridgewater, NJ, is a fully-integrated pharmaceutical company engaged in developing, manufacturing, and distributing generic and specialty drugs.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE:AMRX), headquartered in Bridgewater, NJ, is a fully-integrated pharmaceutical company focused on the development, manufacturing and distribution of generic and specialty drug products. The Company has operations in North America, Asia, and Europe, working together to bring high-quality medicines to patients primarily within the United States.
Amneal has an extensive portfolio of approximately 250 product families and is expanding its portfolio to include complex dosage forms, including biosimilars, in a broad range of therapeutic areas. The Company also markets a portfolio of branded pharmaceutical products through its Specialty segment focused principally on central nervous system and endocrine disorders.
The Company also owns
Company: |
Amneal Pharmaceuticals |
|
|
|
|
Headquarters Address: |
400 Crossing Blvd. |
|
|
Oakland, NJ 08807 |
|
|
|
|
Main Telephone: |
908-947-3120 |
|
|
|
|
Website: |
||
|
|
|
Ticker: |
AMRX(NYSE) |
|
|
|
|
Type of Organization: |
Public |
|
|
|
|
Industry: |
Pharmaceutical |
|
|
|
|
Key Executives: |
President & Co-CEO: Chirag Patel |
|
|
Co-CEO: Chintu Patel |
|
|
CFO: Tasos Konidaris |
|
|
|
|
Investor Relations |
|
|
Contact: |
Investor Relations |
|
Phone: |
908-947-3120 |
|
Email: |
||
|
|
|
Public Relations |
|
|
Contact: |
Media Relations |
|
Phone: |
908-947-3120 |
|
Email: |